KFDA won legal battle on bioequivalency manipulation case.

Published: 2007-04-26 06:58:00

Updated: 2007-04-26 06:58:00

The KFDA won the lawsuit against the case of drug manipulated bio equivalency tests earlier raised by Schnell Pharm. Korea. The Seoul Administrative court decided to reject the lawsuit raised by Schnell Korea on the subject of "Withdrawal of KFDA's cancellation order of the drug registration caus...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK